Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5′-Nucleotidase Inhibitors
Lucas G. Viviani, Erika Piccirillo, Henning Ulrich, et al.
Journal of Chemical Information and Modeling (2019) Vol. 60, Iss. 2, pp. 621-630
Closed Access | Times Cited: 20

Showing 20 citing articles:

Decision Making in Structure-Based Drug Discovery: Visual Inspection of Docking Results
André Fischer, Martin Smieško, Manuel Sellner, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2489-2500
Closed Access | Times Cited: 183
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39
Jenna L. Jeffrey, Kenneth V. Lawson, Jay P. Powers
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13444-13465
Closed Access | Times Cited: 63
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
Ana Maria Oliveira Battastini, Fabrício Figueiró, Daniela Bitencourt Rosa Leal, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
Acyclic purine and pyrimidine nucleotide analogs as ecto-5’-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Břehová, et al.
European Journal of Medicinal Chemistry (2025), pp. 117653-117653
Open Access
Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production
Xiaohui Du, Jared T. Moore, Brian R. Blank, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 18, pp. 10433-10459
Closed Access | Times Cited: 31
Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present)
Alessio Nocentini, Clemente Capasso, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 10, pp. 867-876
Closed Access | Times Cited: 25
Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds
Mingxue Zhang, Xiaoqin Dai, Yu Xiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115546-115546
Closed Access | Times Cited: 10
Small molecular CD73 inhibitors: Recent progress and future perspectives
Gong-hui Ge, Qiu-yin Wang, Zhen-hao Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116028-116028
Closed Access | Times Cited: 8
Ligand- and Structure-Based Virtual Screening in Drug Discovery
Shome S. Bhunia, Mridula Saxena, Anil K. Saxena
Topics in medicinal chemistry (2021), pp. 281-339
Closed Access | Times Cited: 17
Advances in machine intelligence‐driven virtual screening approaches for big‐data
Neeraj Kumar, Vishal Acharya
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 939-974
Closed Access | Times Cited: 6
Targeting ecto-5′-nucleotidase: A comprehensive review into small molecule inhibitors and expression modulators
Gustavo Machado das Neves, Luciano Porto Kagami, Ana Maria Oliveira Battastini, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115052-115052
Closed Access | Times Cited: 9
A Hybrid Approach Combining Shape-Based and Docking Methods to Identify Novel Potential P2X7 Antagonists from Natural Product Databases
Natiele Carla da Silva Ferreira, Lucas G. Viviani, Lauro M. Lima, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 592-592
Open Access | Times Cited: 1
Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement—an in-depth review
R. Huzaifa Sharafat, Aamer Saeed
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor
Yuan Wang, Chuanhao Wang, Yazhao Zhu, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 34, pp. 127758-127758
Closed Access | Times Cited: 11
A new sight to explore site-specific N-glycosylation in donkey colostrum milk fat globule membrane proteins with glycoproteomics analysis
Boyuan Guan, Yuxia Chai, Xiakouna Amantai, et al.
Food Research International (2022) Vol. 162, pp. 111938-111938
Closed Access | Times Cited: 5
Identification of novel human 15-lipoxygenase-2 (h15-LOX-2) inhibitors using a virtual screening approach
Lucas G. Viviani, T. Iijima, Erika Piccirillo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Targeting CD73 for anti-tumor immunity
Shi Liu, Pierre-Antoine Laurent, Éric Deutsch, et al.
Elsevier eBooks (2024)
Closed Access
Identification of Novel Human 15-Lipoxygenase-2 (h15-LOX-2) Inhibitors Using a Virtual Screening Approach
Lucas G. Viviani, T. Iijima, Erika Piccirillo, et al.
Journal of Medicinal Chemistry (2024)
Open Access
Molecular Dynamics Simulations of the Human Ecto-5′-Nucleotidase (h-ecto-5′-NT, CD73): Insights into Protein Flexibility and Binding Site Dynamics
Lucas G. Viviani, Daria B. Kokh, Rebecca C. Wade, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4691-4707
Closed Access | Times Cited: 1
Discovery of the ((diaryl)methyl)phosphonic acid derivatives as novel CD73 inhibitors
Wenyu Yang, Xi Chen, Xiang-Li Ning, et al.
Journal of Heterocyclic Chemistry (2023) Vol. 60, Iss. 12, pp. 1959-1975
Closed Access | Times Cited: 1
Outlook on the Development and Application of Molecular Simulations in Latin America
Thereza A. Soares, Habibah A. Wahab
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 2, pp. 435-438
Closed Access | Times Cited: 2
Page 1

Scroll to top